Ocean Biomedical Inc (OCEA) At $0.15 Offering A Unique Opportunity

Ocean Biomedical Inc (NASDAQ:OCEA) currently has a daily average trading volume of 3.90M but it saw 2568400 shares traded in last market. With a market cap of 5.09M USD, the company’s current market price of $0.15 came falling about -8.81 while comparing to the previous closing price of $0.16. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.79 and as low as $0.16. In the recent trading on the day, stock has struck highest price mark of $0.14 while lowest mark touched by it was $0.155.

Taking a look at 20-day trading activity of Ocean Biomedical Inc (OCEA) gives us an average price of $0.4335, while its current price level is -98.13% below from 52-week high level whereas it is -6.47% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5685 while that of 200 days or SMA-200 reads an average of $1.0134. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.73% during that period while stretching the period over a month that increases to 23.44%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.67 which implies that the stock is in oversold territory.

Over the week, OCEA’s stock price is moving -39.98% down while it is -79.99% when we observe its performance for the past one month. Year-to-date it is -73.62% down and over the past year, the stock is showing a downside performance of -73.78%.

The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Ocean Biomedical Inc’s total number of outstanding shares is 34.87M with 71.99% of that held by the insiders while 10.54% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1691.47%. Stock’s beta reads 1.31. Its return on asset (ROA) is -2461.30% on average.